Committee D Members

Professor Peter Clark (Chair)
Consultant Medical Oncologist, Clatterbridge Centre for Oncology

Professor Peter Clark has been a consultant medical oncologist in Merseyside for over 20 years, specialising in the management of testicular, breast and colorectal cancers. His main oncological interests have been in optimising equity of care in cancer, bringing chemotherapy and clinical trials out of cancer centres into cancer units, raising the overall quality and safety of chemotherapy services and providing value-for-money in cancer services. He is a past medical director of his Trust and chairs the National Chemotherapy Implementation Group for the National Cancer Action Team.

Professor Darren Ashcroft
Professor of Pharmacoepidemiology, School of Pharmacy and Pharmaceutical Sciences, University of Manchester

Biography to follow

Dr Matthew Bradley
Therapy Area Leader, Global Health Outcomes, GlaxoSmithKline

Dr Matt Bradley is a Therapy Area Leader for GlaxoSmithKline Prior to this Matt was a Value Demonstration leader for AstraZeneca Global Research and Development. He has previously been responsible for the coordination and delivery of an integrated programme of HTA across the Sanofi-Aventis portfolio in the UK and has also worked for Pfizer. Prior to moving into the Pharmaceutical Industry Matt was a Senior Research Fellow at the NHS Centre for Reviews and Dissemination (CRD), a lead reviewer for the Cochrane Collaboration, an author of strategic reports for the NHS HTA programme, the Department of Health and the Prime Minister's Office (UK Government). Matt currently chairs the Association of British Pharmaceutical Industries TDA User Group. Matt is a peer reviewer for the NHS HTA programme and sits as required on the New Medicines Group (NMG) for the All Wales Medicines Strategy Group.

Dr Ian Campbell, OBE MD FRCP
Honorary Consultant Physician, Llandough Hospital, Cardiff

Ian Campbell was consultant in Thoracic Medicine in Cardiff from 1978 to 2010. His special interests are tuberculosis, smoking cessation/prevention, opportunist microbacterial lung diseases and pulmonary thrombo-embolism, in which areas he has designed and co-ordinated many local and multi-centre, clinical trials and written chapters in a number of textbooks. He chaired the Research Committee of the British Thoracic Society in 2003.

Although firmly committed to the NHS, Dr Campbell has had a regular session in private practice for over 24 years and has some experience also in medicological reporting.

Currently Dr Campbell remains involved in clinical medicine, as a member of the National Speciality Advisory Group in Respiratory Medicine (Wales), on the board of ASH (Wales), on the board of Trustees of the Britain-Nepal Medical Trust and is the secretary is the Honorary Secretary of the Scadding-Morrsiton Davies Fellowship fund.

Professor Usha Chakravarthy
Professor of Ophthalmology and Vision Sciences, The Queen's University of Belfast

Usha Chakravarthy is the Professor of Ophthalmology and Vision Sciences in The Queen's University of Belfast and is consultant in the Ophthalmic Division in the Belfast Trust. her main clinical interest is in the field of age-related eye diseases. Professor Chakravarthy has a varied portfolio of research interests, her current research involving studies on understanding degenerative aging changes contributing to sight loss in older adults. She has acted as the chief investigator in multicentre clinical trials and studies and is currently the chief investigator for the UK wide HTA funded IVAN clinical trial on alternative drug treatments for exudative age-related macular degeneration. She is involved in large scale population based studies which seeks to identify the important risk factors for sight loss in older people in the developing countries.

Professor Chakravarthy has delivered many eponymous and other invited lectures in the UK and abroad and sits on the scientific advisory boards of the Medical Research Council of the UK, the Royal College of Ophthalmologists of the UK, the Deutsche Forschung Gemainshaft, the AMD Alliance International, and several other national and international scientific organisations and has been on the editorial board of the EYE journal, British Journal of Ophthalmology, Investigative Ophthalmology, Current Eye Research and International Ophthalmology.

Professor Chakravarthy represented the Royal College of Ophthalmologists on the Citizens Council for NICE and has been a member of The Topic selection panel for NICE for over 5 years. She became a member of the Technology

Dr Ian Davidson
Lecturer in Rehabilitation, The University of Manchester

Biography to follow

Professor Simon Dixon
Professor of Health Economics, University of Sheffield

Simon Dixon works in the Health Economics and Decision Science (HEDS) section of the School of Health and Related Research (ScHARR) within the University of Sheffield. Most of his work has examined the cost-effectiveness of health technologies. A separate stream of work examining the use of willingness to pay to value non-health benefits of health care is also ongoing. He also undertakes work for the Department of Health's Policy Research Unit in Economic Evaluation of Health and Care Interventions (EEPRU) based in Sheffield/York. He teaches on three Masters programmes within ScHARR and supervises several PhD students.

Dr Martin Duerden
Assistant Medical Director (Primary Care), Betsi Cadwaladr University Health Board, North Wales

Dr Martin Duerden qualified in medicine from Newcastle University in 1982 and has worked as a GP since 1986. He obtained a Masters qualification in public health at Cambridge University in 1997. He has had a longstanding interest in applying evidence-based medicine to prescribing and therapeutics and previously worked for the National Prescribing Centre and for the Department of Medicines Management at Keele University. For the last 10 years he has worked as a part-time GP in Conwy, north Wales, and now also works as Head of Primary Care Medicine covering Conwy and Denbighshire for Betsi Cadwaladr University Health Board in North Wales. He helps to organise and run the Diploma in Therapeutics at Cardiff University where he is an Honorary Senior Lecturer. He chairs the New Medicines Group for Wales.

Dr Alexander Dyker
Consultant Physician, Wolfson Unit of Clinical Pharmacology

Dr Alexander (Sandy) Dyker studied Immunology and Medicine at the University of Glasgow training as a lecturer in Clinical Pharmacology General Medicine and Stroke Medicine at the University Department of Medicine of the Western Infirmary Glasgow. In 2001 he was appointed as a Consultant Physician in Clinical Pharmacology, Stroke and General Medicine at the Freeman Hospital Newcastle upon Tyne. His clinical and research experience includes medicines management, acute treatments for stroke, treatment of hypertension and Research Ethics.

Gillian Ells BPharm, PGDip, MSc
Prescribing Advisor - Commissioning. NHS Hastings and Rother and NHS East Sussex Downs and Weald

Gillian Ells is a pharmacist working for two primary care trusts on the south east coast of England. Her previous experience includes working in both the hospital and the community sector. She has spent the past 10 years in primary care as a pharmaceutical advisor and now specialises in the commissioning of new drug treatments and management of the local health economy drug formulary. Gillian has recently completed a Masters in Health Economics and Health Policy at Birmingham University.

Dr Jon Fear
Consultant in Public Health Medicine, Head of Healthcare Effectiveness NHS Leeds

Dr Jon Fear BSc MBChB MPH FFPH is an experienced Consultant in Public Health Medicine with senior Public Health leadership experience in a variety of organisations and settings, including Board level responsibility as Director of Public Health. He is Head of Health Care Effectiveness and Deputy Director of Public Health for NHS Leeds. He has a particular interest in intelligence led Commissioning.

Paula Ghaneh
Senior Lecturer and Honorary Consultant, University of Liverpool

Paula Ghaneh is a Senior Lecturer in the School of Cancer Studies at the University of Liverpool and an Honorary Consultant Surgeon at the Royal Liverpool University Hospital. Her clinical specilaity is hepato-pancreato-biliary surgery. Her research interests are pancreatic cancer and clinical trials. She is the Assistant Director of the Cancer Research UK Liverpool Cancer Trials Unit. She is a member of the NCRI pancreatic cancer subgroup.

Susan Griffin, MSc BSc
Research Fellow, Centre for Health Economics, University of York

Susan joined the Centre for Health Economics, University of York in 2002 and holds a BSc in Economics and an MSc in Health Economics. In 2008 Susan became a Research Council UK Academic Fellow in Health Economics and Public Health. Her research interests include the use of decision-analytic models in cost-effectiveness analysis and the use of evidence synthesis techniques and value of information analysis. Susan has worked on economic evaluations in the fields of cardiovascular disease, HIV/AIDS, cancer and mental health. Susan is currently researching the application of methods for economic evaluation in the field of public health.

Professor Carol Haigh
Professor in Nursing, Manchester Metropolitan University

Carol is the Professor in Nursing at Manchester Metropolitan University. From a clinical background in orthopaedic trauma, Carol moved into post registration education in 1989. She developed and ran an MSc in Pain Management at the University of Salford before joining MMU as Professor in Nursing. Her PhD centred on osteoporosis and her other research interests include pain management, patient experience and organization of care. She has published widely on the subjects of pain management and research methods and ethical issues especially those surrounding the use of the Internet for research. Carol is the Associate Editor for the Clinical Issues of the Journal of Clinical nursing. She is also an elected Steering Committee member of the Royal College of Nursing Research Dociety and a fellow of the Royal Statistical Society.

Professor John Hutton
Professor of Health Economics, University of York

John Hutton manages a programme of research on health care innovation and evaluation of health technologies at YHEC, and holds a chair in health economics in the Department of Health Sciences, at the University of York. Previous positions have included Director of European Operations for MEDTAP International and Senior Research Fellow in the Centre for Health Economics at York. He is a founding Editor of Health Economics. Other roles include acting as a non-executive director of the NHS Innovation Hub for Yorkshire and the Humber, and non-executive director and Vice Chair of the York Hospitals NHS Foundation Trust.

Professor Peter Jones
Emeritus Professor of Statistics Keele University

Peter Jones has recently retired as Pro Vice-Chancellor for Research and Enterprise at Keele. Other roles have included Dean of Natural Sciences and Head of the Mathematics Department. His research interests are in the design of clinical trials and modelling genetic effects on severity and susceptibility of disease. He is a non executive director of the Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust in Oswestry and a governor of Newcastle under Lyme School.

Dr Steven Julious
Reader in Medical Statistics, University of Sheffield

After completing his first degree at Manchester and masters at Reading Steven's first role was at the University of Southampton where he was for a number of years before entering the pharmaceutical industry. His last role was at GlaxoSmithKline where he completed his PhD part time at University College London. He joined the University of Sheffield in 2004 where he is currently a Senior Lecturer in Medical Statistics. Steven was editor of the journal Pharmaceutical Statistics and has a research interest in early phase trials and clinical trial design.

Dr Vincent Kirkbride MB BS MRCP MRCPCH MSc MBA MA
Consultant Paediatrician Royal Hallamshire Hospital Sheffield

Dr Kirkbride qualified in 1988 and has been a consultant since 1997. He trained in London, Toronto and Melbourne. His clinical practice is in newborn intensive care and he has a special interest in renal disease and newborn ethics. He is Chairman of the Sheffield Teaching Hospitals Trust Clinical Ethics Committee and also contributes to the ethics modules on the MBChB and LLB programmes at the University of Sheffield. He is training programme director for paediatrics in Yorkshire and speciality adviser to the Royal College of Paediatrics and Child Health. As a father of six children he regularly mediates in household disputes, fixes broken toys and seeks a quiet corner of the house for five minutes peace and quiet.

Rachel Lewis
Advanced Nurse Practitioner, Manchester Business School

Biography to follow

Professor Paul Little
GP Professor of Primary Care Research

Paul Little is a GP and Professor of Primary Care Research in the Primary Care and Population Sciences division of the University of Southampton Faculty of Medicine. His main research interests are the management of common infections and empowering self help for a range of acute and chronic conditions, and has used a variety of research methods ranging from diagnostic studies to development and trialling of complex interventions. He has served on several MRC and NIHR funding Boards, and has also served several NICE panels both as member and as a panel chair.

Professor Jonathan Michaels
Professor of Clinical Decision Science, University of Sheffield

Jonathan Michaels is Professor of Clinical Decision Science in the School of Health and Related Research (ScHARR) in the University of Sheffield. Previously he was Professor of Vascular Surgery in the University of Sheffield from 2004 and Consultant Vascular Surgeon at Sheffield Teaching Hospital NHS Trust from 1994. Prior to this he was Clinical Lecturer in the Nuffield Department of Surgery in Oxford. He has a long-standing interest in technology appraisal, decision theory and economic analysis. Previous research includes commissioned work for the NHS Health Technology Assessment Programme around the organisation of vascular services, clinical trials in vascular disease and the cost effectiveness of new technologies. He currently chairs the Interventional Procedures Panel for the HTA Programme and is chair of a Guideline Development Group for NICE.

Professor Oluwafemi Oyebode
Professor of Psychiatry & Consultant Psychiatrist, The National Centre for Mental Health

Femi Oyebode graduated in Medicine in 1977. He has been Consultant Psychiatrist in Birmingham since 1986. He is currently Professor of Psychiatry at the University of Birmingham. He is on the Editorial Boards of the British Journal of Psychiatry, the Psychiatric Bulletin and Advances in Psychiatric Treatment. His research interests include Clinical Psychopathology, Medical Humanities and Medical Ethics

Dr John Radford
Director of Public Health, Rotherham Primary Care Trust and MBC

Dr Radford was a GP in Sheffield before undertaking Public Health training. He was previously Director of Public Health in Doncaster and has been Director of Public Health and Medical Director including prescribing lead in Rotherham from 2002 to 2011. Following the devolution of Primary Care Trust provider arms and the development of GP commissioning he now works as the joint DPH for Rotherham MBC and the PCT.

Dr Radford continues to work in General Practice. His interests include evidence based prescribing and untoward incident analysis and learning. He chairs the Child Death Overview Panel and is a member of Rotherham Safeguarding Children Board.

Dr Philip Rutledge
GP and Consultant in Medicines Management, NHS Lothian

Dr Rutledge is a Consultant in Public Health and Health Policy in NHS Lothian, Edinburgh, with a special interest in health technology assessment and the introduction of health technologies into NHS clinical practice. Having trained as a GP he previously worked in a group practice near Leith Docks, for 13 years, with a special interest in GP education, sports medicine and drug prescribing. He is past Chair of the Lothian Formulary Committee and Area Drug and Therapeutics Committee, and was a founder member of the Scottish Medicines Consortium. He is Chair of the Scottish Health Technology Group.

Dr Brian Shine
Consultant Chemical Pathologist, John Radcliffe Hospital

Brian Shine has been a consultant chemical pathologist in the Oxford Radcliffe Hospitals Trust since 2001. He previously worked at Stoke Mandeville Hospital, Moorfield Eye Hospital, the Institute of Opthalmology and St. Bartholomew's Hospital. His clinical interests include endocrinology (thyroid cancer and neuroendocrine tumours) and metabolic disorders (electrolyte disorders, metabolic bone disease, inherited metabolic diseases). He has published in endocrinology, cystic fibrosis, diabetes, decision analysis, assay method development, and clinical biochemistry. He teaches evidence based medicine and has an MSc in applied statistics.

Dr Murray Smith
Associate Professor in Social Research in Medicines and Health, University of Nottingham

Biography to follow

Paddy Storrie MA (Oxon) PGCE PGDip NPQH
Lay Member

A graduate historian, Paddy Storrie is Deputy Headmaster of a large state secondary school where he is daily faced with the same essential conundrum as NICE appraisals: the needs and interests of the individual versus the needs of a broader community. Neither a professor nor a clinician, Paddy brings to the committee extensive experience as a critical consumer of healthcare, and from a number of years as a member of the NICE Citizen's Council. Beyond education and NICE Paddy was a member of the recent Academy of Medical Sciences working party into the governance of clinical research, and speaks regularly to a range of audiences on the problems of making healthcare appropriately responsive to communal needs. Other projects include working with Stonewall on their national campaign to reduce the prevalence of homophobic bullying in schools. Interests include cricket, lacrosse, learning modern foreign languages, and travelling with his wife and three children in Scandinavia and Eastern Europe.

Charles Waddicor
Chief Executive, NHS Berkshire West

Biography to follow